• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复高压氧预处理可诱导行冠状动脉旁路移植术患者的心肌和脑保护:一项前瞻性、随机、对照临床试验。

Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.

机构信息

Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

出版信息

J Cardiothorac Vasc Anesth. 2011 Dec;25(6):908-16. doi: 10.1053/j.jvca.2011.06.017. Epub 2011 Aug 25.

DOI:10.1053/j.jvca.2011.06.017
PMID:21868252
Abstract

OBJECTIVES

To evaluate the cerebral and myocardial protective effects of hyperbaric oxygen preconditioning in both on-pump and off-pump coronary artery bypass graft surgery.

DESIGN

A prospective, randomized, single-blinded study including patients scheduled for elective on-pump or off-pump surgery between December 2007 and February 2009.

SETTING

A tertiary care university teaching hospital.

PARTICIPANTS

Forty-nine elective on-pump or off-pump coronary artery bypass graft surgery patients.

INTERVENTIONS

Patients were randomized to either the control (15 patients with on-pump procedure and 10 patients with off-pump procedure, respectively) or hyperbaric oxygen (HBO; 14 patients with on-pump procedure and 10 patients with off-pump procedure, respectively) groups. Patients in the HBO groups underwent preconditioning for 5 days before surgery.

MEASUREMENTS AND MAIN RESULTS

On-pump coronary artery bypass graft surgery patients preconditioned with HBO had significant decreases in S100B protein, neuron-specific enolase, and troponin I perioperative serum levels compared with the on-pump control group. Postsurgically, patients in the on-pump HBO group had a reduced length of stay in the intensive care unit and a decreased use of inotropic drugs. Serum catalase activity 24 hours postoperatively was significantly increased compared with the on-pump control group. In the off-pump groups, there was no difference in any of the same parameters.

CONCLUSIONS

Preconditioning with HBO resulted in both cerebral and cardiac protective effects as determined by biochemical markers of neuronal and myocardial injury and clinical outcomes in patients undergoing on-pump coronary artery bypass graft surgery. No protective effects were noted in off-pump coronary artery bypass graft surgery.

摘要

目的

评估高压氧预处理对体外循环和非体外循环冠状动脉旁路移植术的脑和心肌保护作用。

设计

这是一项前瞻性、随机、单盲研究,纳入了 2007 年 12 月至 2009 年 2 月间择期行体外循环或非体外循环冠状动脉旁路移植术的患者。

地点

一家三级护理大学教学医院。

参与者

49 例择期行体外循环或非体外循环冠状动脉旁路移植术的患者。

干预措施

患者随机分为对照组(体外循环组各 15 例,非体外循环组各 10 例)或高压氧(HBO)组(体外循环组各 14 例,非体外循环组各 10 例)。HBO 组患者在术前 5 天进行预处理。

测量和主要结果

与体外循环对照组相比,HBO 预处理的体外循环冠状动脉旁路移植术患者围手术期 S100B 蛋白、神经元特异性烯醇化酶和肌钙蛋白 I 血清水平显著降低。术后,体外循环 HBO 组患者 ICU 住院时间缩短,正性肌力药物使用减少。术后 24 小时血清过氧化氢酶活性显著升高,与体外循环对照组相比差异有统计学意义。非体外循环组中,相同参数无差异。

结论

体外循环冠状动脉旁路移植术患者采用 HBO 预处理,通过神经元和心肌损伤的生化标志物和临床结果确定具有脑和心肌保护作用。非体外循环冠状动脉旁路移植术无保护作用。

相似文献

1
Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.重复高压氧预处理可诱导行冠状动脉旁路移植术患者的心肌和脑保护:一项前瞻性、随机、对照临床试验。
J Cardiothorac Vasc Anesth. 2011 Dec;25(6):908-16. doi: 10.1053/j.jvca.2011.06.017. Epub 2011 Aug 25.
2
Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery.高压氧预处理可改善心肌功能,缩短重症监护时间,并减少冠状动脉搭桥手术后的并发症。
Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):8-19. doi: 10.1016/j.carrev.2009.03.004.
3
Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.异氟烷预处理对冠状动脉搭桥手术患者的心脏保护作用。
Eur J Anaesthesiol. 2006 Oct;23(10):841-7. doi: 10.1017/S0265021506000354. Epub 2006 Mar 1.
4
Myocardial metabolism altered by ischemic preconditioning and enflurane in off-pump coronary artery surgery.非体外循环冠状动脉手术中缺血预处理和恩氟烷对心肌代谢的影响
J Cardiothorac Vasc Anesth. 2008 Jun;22(3):369-76. doi: 10.1053/j.jvca.2007.12.023. Epub 2008 Mar 24.
5
Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization.非体外循环与体外循环下多支冠状动脉血运重建随机对照研究的早期结果
Circulation. 2005 Aug 30;112(9 Suppl):I338-43. doi: 10.1161/CIRCULATIONAHA.104.524504.
6
Resource utilization in on- and off-pump coronary artery surgery: factors influencing postoperative length of stay--an experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia.非体外循环与体外循环冠状动脉搭桥手术中的资源利用:影响术后住院时间的因素——1746例接受快通道心脏麻醉的连续患者的经验
J Cardiothorac Vasc Anesth. 2005 Feb;19(1):26-31. doi: 10.1053/j.jvca.2004.11.005.
7
Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.冠状动脉搭桥术中的心肌损伤:通过测量高敏C反应蛋白、心肌肌钙蛋白I、心型脂肪酸结合蛋白、肌酸激酶同工酶MB和肌红蛋白释放量对体外循环与非体外循环进行比较
J Thorac Cardiovasc Surg. 2008 May;135(5):1110-9, 1119.e1-10. doi: 10.1016/j.jtcvs.2007.12.029.
8
Neurocognitive outcomes of off-pump versus on-pump coronary artery bypass: a prospective randomized controlled trial.非体外循环与体外循环冠状动脉搭桥术的神经认知结局:一项前瞻性随机对照试验。
Ann Thorac Surg. 2007 Dec;84(6):1897-903. doi: 10.1016/j.athoracsur.2007.07.036.
9
Serum S-100 beta protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass.冠状动脉搭桥手术中使用或不使用体外循环时的血清S-100β蛋白
Ann Thorac Surg. 2005 Oct;80(4):1371-4. doi: 10.1016/j.athoracsur.2005.04.011.
10
Neurocognitive function in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass: the effect of two different rewarming strategies.接受体外循环冠状动脉搭桥手术患者的神经认知功能:两种不同复温策略的影响。
J Cardiothorac Vasc Anesth. 2009 Feb;23(1):14-21. doi: 10.1053/j.jvca.2008.07.010. Epub 2008 Sep 24.

引用本文的文献

1
Application and progress of hyperbaric oxygen therapy in cardiovascular diseases.高压氧疗法在心血管疾病中的应用与进展
Med Gas Res. 2025 Sep 1;15(3):427-434. doi: 10.4103/mgr.MEDGASRES-D-24-00107. Epub 2025 Apr 17.
2
Hyperbaric oxygen therapy for cardiovascular surgery.心血管手术的高压氧治疗。
Med Gas Res. 2025 Jun 1;15(2):299-308. doi: 10.4103/mgr.MEDGASRES-D-24-00095. Epub 2025 Jan 22.
3
Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality?内皮功能障碍与心血管疾病:高压氧治疗会成为一种新兴的治疗方式吗?
J Cardiovasc Dev Dis. 2024 Dec 19;11(12):408. doi: 10.3390/jcdd11120408.
4
The Effect of Hyperbaric Oxygen Therapy on Markers of Oxidative Stress and the Immune Response in Healthy Volunteers.高压氧疗法对健康志愿者氧化应激标志物和免疫反应的影响。
Front Physiol. 2022 Jan 31;13:826163. doi: 10.3389/fphys.2022.826163. eCollection 2022.
5
The Effects of Hyperbaric Oxygenation on Oxidative Stress, Inflammation and Angiogenesis.高压氧对氧化应激、炎症和血管生成的影响。
Biomolecules. 2021 Aug 14;11(8):1210. doi: 10.3390/biom11081210.
6
An Extra Breath of Fresh Air: Hyperbaric Oxygenation as a Stroke Therapeutic.呼吸新鲜空气:高压氧治疗作为中风的一种治疗方法。
Biomolecules. 2020 Sep 4;10(9):1279. doi: 10.3390/biom10091279.
7
Hypoxia-inducible factor-1α in acute ischemic stroke: neuroprotection for better clinical outcome.急性缺血性卒中中的缺氧诱导因子-1α:神经保护作用以改善临床结局
Heliyon. 2020 Jun 28;6(6):e04286. doi: 10.1016/j.heliyon.2020.e04286. eCollection 2020 Jun.
8
Hyperbaric Oxygen Preconditioning Can Reduce Postabdominoplasty Complications: A Retrospective Cohort Study.高压氧预处理可减少腹部整形术后并发症:一项回顾性队列研究。
Plast Reconstr Surg Glob Open. 2019 Oct 31;7(10):e2417. doi: 10.1097/GOX.0000000000002417. eCollection 2019 Oct.
9
Effect of intermittent hyperoxia on stem cell mobilization and cytokine expression.间歇性高氧对干细胞动员和细胞因子表达的影响。
Med Gas Res. 2019 Jul-Sep;9(3):139-144. doi: 10.4103/2045-9912.266989.
10
Evidence for simulation-based education in hyperbaric medicine: A systematic review.高压氧医学中基于模拟的教育的证据:一项系统综述。
Diving Hyperb Med. 2019 Sep 30;49(3):209-215. doi: 10.28920/dhm49.3.209-215.